Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.23.2
Description of Business and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2023
Protein Sciences | QT Holdings Corporation  
Notes Tables  
Schedule of restructuring charges The related restructuring charges for the year ended June 30, 2023 were recorded in the income statement as follows (in thousands):

Employee

Asset

    

severance

    

impairment and other

    

Total

Selling, general and administrative

$

1,328

$

842

$

2,170

Employee

Asset

    

severance

    

impairment and other

    

Total

Expense incurred in the first quarter of 2023

$

1,328

$

842

$

2,170

Cash payments

(1,233)

(772)

(2,005)

Adjustments

(95)

(70)

(165)

Accrued restructuring actions balances as of June 30, 2023

$

$

$

Protein Sciences | Employee Severance [Member]  
Notes Tables  
Schedule of restructuring charges Restructuring actions, including cash and non-cash impacts, are as follows (in thousands):

Employee

severance

Expense incurred in the second quarter of 2023

$

780

Expense incurred in the fourth quarter of 2023

897

Cash payments

(762)

Adjustments

(18)

Accrued restructuring actions balances as of June 30, 2023

$

897

Diagnostics and Genomics  
Notes Tables  
Schedule of restructuring charges Total restructuring charges for the closure of the Exosome Diagnostics Germany facility for the year ended June 30, 2022 were recorded within operating income on the income statement as follows (in thousands):

Employee

Asset

    

Severance

    

Impairment and other

    

Total

Selling, general and administrative

$

649

$

750

$

1,399

Employee

Asset

    

Severance

    

Impairment and other

    

Total

Expense incurred in the first quarter of 2022

$

639

$

546

$

1,185

Incremental expense incurred during fiscal 2022

242

242

Cash payments

(589)

(554)

(1,143)

Adjustments(1)

(50)

(234)

(284)

Accrued restructuring actions balances as of June 30, 2022

$

(1) Adjustments include refinements to our estimated close down costs as well as the impacts from foreign currency exchange.